AHA calls for extension of remote prescribing flexibilities: 6 things to know

Becker's Healthcare October 7, 2024
Naomi Diaz

The American Hospital Association sent a letter to Chiquita Brooks-LaSure, the Administrator of CMS, urging her to ensure continued access to remote prescribing for controlled substances.

Six things to know:

1. During the COVID-19 pandemic, the Drug Enforcement Administration temporarily relaxed certain regulations to allow healthcare providers to prescribe specific controlled substances via telehealth. This included stimulant medications for attention-deficit/hyperactivity disorder, anxiety medications, and medications for opioid use disorder, among others. Notably, the DEA also removed the requirement for an in-person visit prior to prescribing these controlled substances.
2. In October 2023, the DEA extended this flexibility until the end of 2024.
3. In a Oct. 4 letter, the AHA said it is concerned that with the expiration date approaching, the...

Today's Sponsors

Today's Sponsor